Stock GH GUARDANT HEALTH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Guardant Health, Inc.

Equities

GH

US40131M1099

Delayed Nasdaq
Other stock markets
 04:00:00 2024-05-22 pm EDT 		5-day change 1st Jan Change
22.51 USD -4.50% Intraday chart for Guardant Health, Inc. -12.58% -16.78%
May. 21 Guardant Health Gets EU Certification for Blood-Based Test for Comprehensive Genomic Profiling of Solid Cancers MT
May. 21 Guardant Health, Inc. Receives EU IVDR Certification for Guardant360® CDx Liquid Biopsy for Tumor Mutation Profiling Across All Solid Cancers and Companion Diagnostic Indications CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Guardant Health Stock Trading Temporarily Halted; FDA Panel to Assess Premarket Approval Application for Shield Blood Test for Colorectal Cancer Screening
BU
Guardant Health to Participate in Upcoming Investor Conferences
BU
Guardant Health Gets EU Certification for Blood-Based Test for Comprehensive Genomic Profiling of Solid Cancers
MT
Guardant Health Receives EU IVDR Certification for Guardant360® CDx Liquid Biopsy for Tumor Mutation Profiling Across All Solid Cancers and Companion Diagnostic Indications
BU
Guardant Health, Inc. Receives EU IVDR Certification for Guardant360® CDx Liquid Biopsy for Tumor Mutation Profiling Across All Solid Cancers and Companion Diagnostic Indications
CI
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(4)
AQ
Guardant Health to present real-world data supporting performance of Shield blood test for colorectal cancer screening at 2024 Digestive Disease Week
AQ
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BU
Guardant Health to present real-world data supporting performance of Shield™ blood test for colorectal cancer screening at 2024 Digestive Disease Week
BU
Transcript : Guardant Health, Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 10:40 AM
Guardant Health Shares Rise After Q1 Adjusted Loss Shrinks, Revenue Rises; 2024 Revenue Guidance Raised
MT
Guardant Health : Q1 2024 Earnings Call - Presentation
PU
Guardant Health: Q1 Earnings Snapshot
AQ
Earnings Flash (GH) GUARDANT HEALTH Reports Q1 Revenue $168.5M, vs. Street Est of $150.1M
MT
Transcript : Guardant Health, Inc., Q1 2024 Earnings Call, May 09, 2024
Guardant Health Reports First Quarter 2024 Financial Results and Increases 2024 Revenue Guidance
BU
Guardant Health, Inc. Raises Financial Guidance for the Full Year of 2024
CI
Guardant Health to Participate in Upcoming Investor Conferences
BU
Guardant Health Surpasses 500 Peer-Reviewed Publications Milestone
BU
Canaccord Genuity Adjusts Price Target on Guardant Health to $30 From $45, Maintains Buy Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GH Stock
  4. News Guardant Health, Inc.